Investor profile
8VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
8VC's 'Smart Enterprise' thesis, articulated in 2013, posits that the next dominant technology wave will be driven by leveraging data integration, enabling human experts to solve non-linear problems, and building platforms that harness network effects to take on entire problem spaces. The firm predicted that 'the smart enterprise wave will disrupt nearly every major sector of the global economy,' and invests across logistics, life sciences, healthcare, IT infrastructure, and government & defense to validate that vision. Founded by Joe Lonsdale (co-founder of Palantir), 8VC partners with elite founders to build transformational technologies that create long-term economic and societal value. The firm is guided by principles of principled contrarianism, positive-sum thinking, and patriotism — believing in the American experiment and that the boundaries between commercial technology, government technology, and national security are converging. When the companies 8VC wants to back don't yet exist, it builds them through its proprietary 'Build' program.
Notable quotes
“We are proud to announce 8VC Fund V, with $880 million in new capital to continue our work supporting and partnering with entrepreneurs at every stage of their journey, and building companies ourselves.”
“For most of 20 years, the naive mainstream view of Palantir was that it was a 'glorified consultancy' — a services firm and not a real tech innovator building SaaS 'products' or 'platforms'. To dismiss Palantir early on was short-sighted, given they'd hired some of Silicon Valley's top tech talent, but it was based on a factual observation: unlike most software businesses, many of our engineers spent significant time working alongside our customers.”
“Being different gets attention. Being different, and right, can change the world.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Anduril Industries | Series C+ | — | — |
| Palantir Technologies | Early Stage | — | — |
| Ramp | Series B+ | — | — |
| Flexport | Series C+ | — | — |
| Guardant Health | Series C+ | — | — |
| Candid Health | Series C | $53m | 2025 |
| Tempero Bio | Series B | $70m | 2025 |
| Latent Labs | Series A | $40m | 2025 |
| Saronic | Series C+ | — | — |
| Resilience | Series C+ | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Khosla Ventures | 12 |
| Founders Fund | 10 |
| General Catalyst | 9 |
| Andreessen Horowitz | 8 |
| Lux Capital | 7 |
| Sequoia Capital | 6 |
Fit check
Is 8VC a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit